| 000 | 01673 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513145706.0 | ||
| 264 | 0 | _c19980805 | |
| 008 | 199808s 0 0 eng d | ||
| 022 | _a0002-9149 | ||
| 024 | 7 |
_a10.1016/s0002-9149(98)00230-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKajinami, K | |
| 245 | 0 | 0 |
_aLow-density lipoprotein receptor genotype-dependent response to cholesterol lowering by combined pravastatin and cholestyramine in familial hypercholesterolemia. _h[electronic resource] |
| 260 |
_bThe American journal of cardiology _cJul 1998 |
||
| 300 |
_a113-7 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnion Exchange Resins _xtherapeutic use |
| 650 | 0 | 4 |
_aAnticholesteremic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBile _xmetabolism |
| 650 | 0 | 4 |
_aCholestyramine Resin _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aHyperlipoproteinemia Type II _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPravastatin _xtherapeutic use |
| 650 | 0 | 4 |
_aReceptors, LDL _xgenetics |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aYagi, K | |
| 700 | 1 | _aHigashikata, T | |
| 700 | 1 | _aInazu, A | |
| 700 | 1 | _aKoizumi, J | |
| 700 | 1 | _aMabuchi, H | |
| 773 | 0 |
_tThe American journal of cardiology _gvol. 82 _gno. 1 _gp. 113-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0002-9149(98)00230-6 _zAvailable from publisher's website |
| 999 |
_c9636954 _d9636954 |
||